Senior Director of Business Development shares insight on industry trends and outsourcing.

Thermo Fisher Scientific Inc. has agreed to acquire Clario Holdings Inc., a provider of digital endpoint data solutions for clinical trials, in a cash transaction valued at $8.875 billion.

Will transfer commercial manufacturing for a leading injectable pharmaceutical product from the current manufacturer to Lifecore’s facilities.

SK pharmteco and Lotte Biologics have signed a Letter of Intent for a strategic collaboration to strengthen their competitiveness in the global ADC market.

Wheeler Bio has partnered with Mitsubishi Corporation to expand its commercial reach and business development activities across the Asia-Pacific region.

New plate-based multiplexing unlocks ultra-high-sample and cell-throughput single cell analysis to empower a broad range of studies.